Myriad Genetics Inc (MYGN) Stock Price, Quote, News & History

MYGNNASDAQ
$4.46
-0.085-1.87%
Last update: Jun 22, 11:56 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
2.40M
Investing Cash Flow (TTM)
-25.60M
Financing Cash Flow (TTM)
47.60M
Free Cash Flow (TTM)
-23.20M
Capital Expenditure (TTM)
-25.60M
Net Change in Cash (TTM)
24.40M

Analyst Trends and Forecast

2
Feb
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
1.9
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$515.89M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.51
PB Ratio (TTM)
1.27
Earnings Yield % (TTM)
-94.83%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.57

Company Debt

Total Debt
$120.30M
LT Debt
$120.30M
LT Debt Issuance (TTM)
$125.00M
LT Debt Repayment (TTM)
-$60.20M
Total Cash
$124.40M
Debt to Equity
0.63
Issuance of Debt (TTM)
$64.80M
Repayment of Debt (TTM)
-$60.20M

Key Statistics

Open
$4.54
Close
-
Volume / Avg.
244.02K / 1.80M
Day Range
$4.46 - $4.62
52 Wk Range
3.53 - 8.59
Market Cap
$420.77M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
54
Short Interest
9.28%
Days to Cover
4.24

About

Sector
Health Care
Industry
Biotechnology
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Myriad Genetics (MYGN) stock?

A

You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Myriad Genetics (MYGN) competitors?

A

There are no as such competitors for Myriad Genetics.

Q

What is the forecast, or price target, for Myriad Genetics (MYGN) stock?

A

Myriad Genetics has a consensus price target of $13.82.

Q

What is the current price for Myriad Genetics (MYGN)?

A

The stock price for Myriad Genetics (NASDAQ: MYGN) is $4.455 last updated June 22, 2026 at 11:56 AM EDT.

Q

Does Myriad Genetics (MYGN) pay a dividend?

A

There are no upcoming dividends for Myriad Genetics.

Q

When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?

A

Myriad Genetics does not have any upcoming earnings scheduled.

Q

Is Myriad Genetics (MYGN) going to split?

A

There is no upcoming split for Myriad Genetics.

Q

What sector and industry does Myriad Genetics (MYGN) operate in?

A

Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.